Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    breast cancer optical margins assessment
Show Display Options
Rank Status Study
1 Completed
Has Results
Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)
Condition: Breast Cancer
Intervention: Device: Optical coherence tomography
2 Recruiting Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)
Condition: Breast Cancer
Intervention: Device: Interferometric Synthetic Aperture Microscopy
3 Completed Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy
Condition: Breast Cancer
Intervention: Procedure: fluorescence spectroscopy and diffuse spectroscopy
4 Recruiting An Optical Assay System for Intra Operative Assessment of Tumor Margins in Patients
Condition: Breast Cancer
Intervention: Device: 49-channel optical spectrometer
5 Recruiting A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins
Condition: Breast Cancer
Interventions: Device: miniature spectral imaging system;   Device: Bench-top optical spectrometer;   Device: High resolution microendoscope
6 Unknown  Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors
Condition: Breast Cancer
Interventions: Procedure: breast biopsy;   Procedure: histopathologic examination;   Procedure: light-scattering spectroscopy;   Procedure: therapeutic conventional surgery
7 Completed Fast Spectral Imaging Device for Tumor Margin Mapping
Condition: Breast Cancer
Intervention:
8 Enrolling by invitation ALA-induced Fluorescence Imaging of Breast Cancers Using the Handheld PRODIGI Imaging Device
Condition: Breast Cancer
Intervention:
9 Unknown  VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer
Condition: Breast Cancer
Intervention: Drug: bevacizumab-IRDye800CW

Indicates status has not been verified in more than two years